Keywords: nci, license, aids, drug, conocurvone, national, cancer

NCI TO LICENSE AIDS DRUG CONOCURVONE

Article | 20 September 1993

Print This

The US National Cancer Institute has offered up for license a new antiviral compound, conocurvone, said to be the most ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in